DE69535337D1 - Transkriptionsfaktor e2f-5 - Google Patents

Transkriptionsfaktor e2f-5

Info

Publication number
DE69535337D1
DE69535337D1 DE69535337T DE69535337T DE69535337D1 DE 69535337 D1 DE69535337 D1 DE 69535337D1 DE 69535337 T DE69535337 T DE 69535337T DE 69535337 T DE69535337 T DE 69535337T DE 69535337 D1 DE69535337 D1 DE 69535337D1
Authority
DE
Germany
Prior art keywords
transcription factor
murine
interact
human
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69535337T
Other languages
English (en)
Other versions
DE69535337T2 (de
Inventor
Rene Bernards
Eleonore Marielle Hijmans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Topotarget UK Ltd
Original Assignee
Topotarget UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Topotarget UK Ltd filed Critical Topotarget UK Ltd
Publication of DE69535337D1 publication Critical patent/DE69535337D1/de
Application granted granted Critical
Publication of DE69535337T2 publication Critical patent/DE69535337T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Fats And Perfumes (AREA)
  • Steroid Compounds (AREA)
DE69535337T 1995-02-14 1995-04-18 Transkriptionsfaktor e2f-5 Expired - Fee Related DE69535337T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9502873 1995-02-14
GBGB9502873.4A GB9502873D0 (en) 1995-02-14 1995-02-14 Transcription factor
PCT/GB1995/000869 WO1996025494A1 (en) 1995-02-14 1995-04-18 Transcription factor - e2f-5

Publications (2)

Publication Number Publication Date
DE69535337D1 true DE69535337D1 (de) 2007-01-25
DE69535337T2 DE69535337T2 (de) 2007-07-05

Family

ID=10769580

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69535337T Expired - Fee Related DE69535337T2 (de) 1995-02-14 1995-04-18 Transkriptionsfaktor e2f-5

Country Status (12)

Country Link
US (1) US6448376B1 (de)
EP (1) EP0809695B1 (de)
JP (2) JPH11500903A (de)
AT (1) ATE348154T1 (de)
AU (1) AU701913B2 (de)
CA (1) CA2211975A1 (de)
DE (1) DE69535337T2 (de)
DK (1) DK0809695T3 (de)
ES (1) ES2279512T3 (de)
GB (1) GB9502873D0 (de)
PT (1) PT809695E (de)
WO (1) WO1996025494A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998013508A1 (en) * 1996-09-24 1998-04-02 Dana-Farber Cancer Institute Method of targeting malignant cells using an e2f responsive promoter
CA2267188A1 (en) * 1996-09-30 1998-04-09 Kyowa Hakko Kogyo Co., Ltd. E2f activity inhibiting compound
EP0860445A1 (de) * 1997-02-18 1998-08-26 Hoechst Aktiengesellschaft Neue Nukleotidsequenzen für zellzyklusabhängige Expression von Strukturgenen
EP0859008A3 (de) * 1997-02-18 2000-04-05 Hoechst Aktiengesellschaft Nucleinsäurekonstrukt für zellzyklusabhängige Expression von Strukturgene
EP1025220B1 (de) 1997-10-21 2007-01-03 The University Court Of The University Of Glasgow Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
CA2328499A1 (en) 1998-06-30 2000-01-06 Genset S.A. A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid
CN1331161A (zh) * 2000-06-28 2002-01-16 上海博德基因开发有限公司 一种新的多肽——人转录因子lcr－f19.02和编码这种多肽的多核苷酸
CN103215288A (zh) 2006-06-08 2013-07-24 巴斯福植物科学有限公司 具有改良生长特性的植物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3609693A (en) * 1992-01-29 1993-09-01 Duke University Method of assaying for the oncogenic state of cells
EP0669976B1 (de) * 1992-10-29 1999-06-16 Medical Research Council Testreihenanalyse-Verfahren mit transkriptionsfaktor DP-1
JPH10509035A (ja) 1994-11-15 1998-09-08 プロリフィックス リミテッド 転写因子ｅ２ｆ−４

Also Published As

Publication number Publication date
PT809695E (pt) 2007-03-30
GB9502873D0 (en) 1995-04-05
AU701913B2 (en) 1999-02-11
JPH11500903A (ja) 1999-01-26
EP0809695B1 (de) 2006-12-13
DE69535337T2 (de) 2007-07-05
US6448376B1 (en) 2002-09-10
EP0809695A1 (de) 1997-12-03
WO1996025494A1 (en) 1996-08-22
ES2279512T3 (es) 2007-08-16
AU2221595A (en) 1996-09-04
JP2006340730A (ja) 2006-12-21
CA2211975A1 (en) 1996-08-22
ATE348154T1 (de) 2007-01-15
DK0809695T3 (da) 2007-04-16

Similar Documents

Publication Publication Date Title
DE68920223D1 (de) Enzymelektroden und ihre Herstellung.
DE68924026T2 (de) Biosensor und dessen herstellung.
DE3883551D1 (de) Druckausbalancierte Dichtung mit "S" Querschnitt.
DE69609149T2 (de) Ungesättigtes Copolymer auf Olefinbasis, seine Herstellung und seine Verwendung
DE68908313D1 (de) Klebverbaende, ihre herstellung und anwendung.
DE3785967T2 (de) Monoklonale Antikörper gegen C5A und DES-ARG74-C5A, ihre Herstellung und ihre Verwendung.
DE59105838D1 (de) Dihydroxypropylsulfoethylcellulosen, ihre Herstellung und Verwendung.
DE69535337D1 (de) Transkriptionsfaktor e2f-5
DE3580432D1 (de) Hochmolekulare polyester, ihre herstellung und verwendung.
DE68900210D1 (de) Pyranobenzoxadiazolderivate, herstellung, verwendung und diese enthaltende zubereitungen.
ATE286908T1 (de) Gewebespezifische expression des retinoblastoma- proteins
YU31697A (sh) Varijante aprotinina sa poboljšanim svojstvima
DE69333302D1 (de) Mikroorganismen, ihre herstellung und verwendung
DE3685743T2 (de) Anthracyclinderivate, ihre verwendung als antitumorsubstanzen und ihre herstellung.
BR9609801A (pt) Petídos cíclicos análogos de somatostina com atividade inibitória do desenvolvimento de hormónio
DE69016693D1 (de) Züchtung von transformierten Mikroorganismen.
DE69011856T2 (de) Herstellung von hefeextrakt.
DE59007730D1 (de) Monoazofarbstoffe, ihre Herstellung und Verwendung.
DE3671033D1 (de) Monoazofarbstoffe, ihre herstellung und verwendung.
DE69705849D1 (de) Herstellung von 3,5-lutidin
DE69004808T2 (de) Antibiotikum N-Acetylbenanomicin B, dessen Herstellung und Verwendung.
RU95114858A (ru) Новый пептидный фрагмент, обладающий биологической активностью инсулина
DE59509427D1 (de) Färbestabiler Monoazofarbstoff, dessen Herstellung und Verwendung
DE58908272D1 (de) Färbestabiler Monoazofarbstoff, dessen Herstellung und Verwendung.
DE58906943D1 (de) Monoazofarbstoffe, ihre Herstellung und Verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee